Oncology Takes the Lead: How the Biosimulation Market Is Transforming Cancer Research
Drug development is expensive, slow, and risky. Biosimulation uses computational models of biological systems to predict how a drug will behave before it reaches patients, and it is becoming central to how pharma and biotech companies cut that risk. Here is what the data says about where the market stands, what is driving it, and who is shaping it. Market Size and Growth Forecasts According to...
0 Kommentare 0 Anteile 45 Ansichten